BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Design and Safety Considerations for Clinical Trials Involvi
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-20427-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20261120
DTEND;VALUE=DATE:20261121
SUMMARY:FDA comments close: Design and Safety Considerations for Clinical 
 Trials Involving Ibogaine Drug Products\; Request for Information
DESCRIPTION:Notice. Federal Register 2026-20427. Docket FDA-2026-N-10429. 
 Details: https://docket-clock.pages.dev/doc/2026-20427/ Official: https:/
 /www.federalregister.gov/documents/2026/10/06/2026-20427/design-and-safet
 y-considerations-for-clinical-trials-involving-ibogaine-drug-products-req
 uest-for
URL:https://www.federalregister.gov/documents/2026/10/06/2026-20427/design
 -and-safety-considerations-for-clinical-trials-involving-ibogaine-drug-pr
 oducts-request-for
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR